Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Expands Dx Business in China, India with Two Acquisitions

NEW YORK (GenomeWeb News) – PerkinElmer has acquired two separate companies, one in China and one in India, in a bid to expand its diagnostics and genetic screening businesses.

The firm said that it has completed its acquisition of SYM-BIO Lifescience, a Shanghai, China-based diagnostics firm for around $63.7 million in cash. SYM-BIO supplied Chinese hospitals with infectious disease diagnostic products. PerkinElmer said that the acquisition doubles its access to hospitals in China, offering the firm a larger base to expand its prenatal and newborn screening business.

The deal also provides PerkinElmer with "substantial" manufacturing plant capacity in Shanghai and the surrounding area.

PerkinElmer also announced that it has acquired the genetic screening business of Surendra Genetic Labs, a lab in Chennai, India, that provides fetal, maternal, and newborn screening.

The firm did not disclose the financial terms of that pact.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.